Stock A195990 ABPRO BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Abpro Bio Co., Ltd.

News Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

End-of-day quote Korea Stock Exchange
Other stock markets
 06:00:00 2023-12-07 pm EST 		Intraday chart for Abpro Bio Co., Ltd. 5-day change 1st Jan Change
613 KRW +1.32% -1.45% +45.26%
May. 15 Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim. CI

Summary

Search
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.
CI
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.
CI
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
CI
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.
CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.
CI
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors
CI
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..
CI
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
CI
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index
CI
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.
CI
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.
CI
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.
CI
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding
CI
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Announcement Date

Since

Until

  1. Stock
  2. Equities
  3. Stock Abpro Bio Co., Ltd. - Korea Stock Exchange
  4. News Abpro Bio Co., Ltd.
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer